Literature DB >> 32680646

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.

Gordon F Tomaselli, Kenneth W Mahaffey, Adam Cuker, Paul P Dobesh, John U Doherty, John W Eikelboom, Roberta Florido, Ty J Gluckman, William J Hucker, Roxana Mehran, Steven R Messé, Alexander C Perino, Fatima Rodriguez, Ravindra Sarode, Deborah M Siegal, Barbara S Wiggins.   

Abstract

Entities:  

Keywords:  ACC Expert Consensus Decision Pathway; apixaban; atrial fibrillation; betrixaban; dabigatran; edoxaban; rivaroxaban; venous thromboembolism; warfarin

Mesh：

Substances：

Year:  2020        PMID： 32680646     DOI： 10.1016/j.jacc.2020.04.053

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  25 in total

1.  Perioperative consultative hematology: can you clear my patient for a procedure?

Authors:  Allison Elaine Burnett; Bishoy Ragheb; Scott Kaatz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.

Authors:  Stefano Ballestri; Elisa Romagnoli; Dimitriy Arioli; Valeria Coluccio; Alessandra Marrazzo; Afroditi Athanasiou; Maria Di Girolamo; Cinzia Cappi; Marco Marietta; Mariano Capitelli
Journal:  Adv Ther       Date:  2022-10-16       Impact factor: 4.070

3.  Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals.

Authors:  Zahir Kanjee; Marissa L McCann; Jason A Freed
Journal:  JAMA Netw Open       Date:  2021-05-03

4.  Anti-factor Xa activity assays of direct-acting oral anticoagulants during clinical care: An observational study.

Authors:  Smrithi Sukumar; Melissa Cabero; Sharon Tiu; Margaret C Fang; Scott C Kogan; Janice B Schwartz
Journal:  Res Pract Thromb Haemost       Date:  2021-05-12

5.  Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database.

Authors:  Moutaz El Kadri; Ahmed Ghorab; Jean Joury; Mohamed Farghaly; Nancy Awad; Badarinath Chickballapur Ramachandrachar; Ashok Natarajan
Journal:  Avicenna J Med       Date:  2021-04-19

6.  Efficacy of prothrombin complex concentrate in the management of oral factor Xa inhibitors associated major bleed assessed by ISTH and ANNEXA-4 criteria.

Authors:  Pallavi Dev; Carol Abousaab; Cecilia Zhou; Ravi Sarode
Journal:  J Thromb Thrombolysis       Date:  2021-08-09       Impact factor: 2.300

7.  Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors.

Authors:  Mary Hormese; Alex Littler; Brian Doane; Nicole Glowacki; Ann Khimani; Nicole Vivacqua; Karina Rudenberg
Journal:  J Thromb Thrombolysis       Date:  2021-03-16       Impact factor: 2.300

8.  Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors-An In Vitro Study.

Authors:  Nina Haagenrud Schultz; Jawed Fareed; Pål Andre Holme
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 9.  Management of Life-Threatening Bleeding in Patients With Mechanical Heart Valves.

Authors:  Syed A Huda; Sara Kahlown; Mohammad H Jilani; Debanik Chaudhuri
Journal:  Cureus       Date:  2021-06-13

Review 10.  Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.

Authors:  Robert Benamouzig; Maxime Guenoun; David Deutsch; Laurent Fauchier
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-18       Impact factor: 3.947
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.